Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

Cytopathology

Volumn 23, Issue 1, 2012, Pages 30-38

  Hofman, V ^a,b,c,d   Long, E ^a,b,c,d   Ilie, M ^a,b,c,d   Bonnetaud, C ^b   Vignaud, J M ^e   Flejou J F ^f   Lantuejoul, S ^d   Piaton, E ^g   Mourad, N ^h   Butori, C ^a,b,c,d   Selva, E ^b   Marquette, C H ^b   Poudenx, M ^b   Sibon, S ^b   Kelhef, S ^b   Venissac N ^b   Jais, J P ⁱ   Mouroux, J ^b   Molina, T J ^j   Vielh, P ^k   Hofman, P ^a,b,c,d   more..

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b PASTEUR HOSPITAL   (France)

^c Laboratory of Clinical and Experimental Pathology   (France)

^d INSERM   (France)

^e Department of Pathology ^*  (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g Department of Pathology   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

^k INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

Circulating tumour cells; Cytopathology; Diagnosis; Interobserver agreement; Isolation by size of epithelial tumour cells; Non small cell lung carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURGERY; CELL ISOLATION; CIRCULATING NON HEMATOLOGICAL CELL; CIRCULATING TUMOR CELL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; ISOLATION BY SIZE OF EPITHELIUM TUMOR CELL METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PATHOLOGIST; PRIORITY JOURNAL; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CELL SEPARATION; CELL SIZE; CYTODIAGNOSIS; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING;

EID: 84855977275     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2010.00835.x     Document Type: Article

References (41)

1. Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev 2010;20:96-9.
2. Paterlini-Bréchot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 2007;253:180-204.
3. Allard WJ, Matera J, Miller MC et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin Cancer Res 2004;10:6897-904.
4. Sandri MT, Zorzino L, Cassatella MC, et al. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann Surg Oncol 2010;17:1539-45.
5. Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008;8:329-40.
6. Krivacic RT, Ladanyi A, Curry DN et al. A rare-cell detector for cancer. Proc Natl Acad Sci U S A 2004;101:10501-4.
7. Vona G, Sabile A, Louha M et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000;156:57-63.
8. Fetsch PA, Cowan KH, Weng DE et al. Detection of circulating tumor cells and micrometastases in stage II, III, and IV breast cancer patients utilizing cytology and immunocytochemistry. Diagn Cytopathol 2000;22:323-8.
9. Marinucci D, Bethel K, Luttgen M et al. Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med 2009;133:1468-71.
10. Pinzani P, Salvadori B, Simi L. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 2006;37:711-8.
11. Vona G, Estepa L, Beroud C et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004;39:792-7.
12. Marrinucci D, Bethel K, Bruce RH et al. Case study of the morphologic variation of circulating tumor cells. Hum Pathol 2007;38:514-9.
13. Marrinucci D, Bethel K, Lazar D et al. Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010;2010:861341.
14. Goya T, Asamura H, Yoshimura H et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005;50:227-34.
15. Marcel T, van Rens M, Brutel de la Rivière A et al. Prognostic assessment of 2, 361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000;117:374-9.
16. Travis WD, Lubin J, Ries L et al. United states lung carcinoma incidence and trends: declining for most histologic types among males, increasing among females. Cancer 1996;77:2464-70.
17. Pantel K, Riethdorf S. Pathology: are circulating tumor cells predictive of overall survival? Nat Rev Clin Oncol 2009;6:190-1.
18. Chen T-F, Jiang G-L, Fu X-L et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer 2007;56:105-14.
19. Gauthier LR, Granotier C, Soria JC et al. Detection of circulating carcinoma cells by telomerase activity. Br J Cancer 2001;84:631-5.
20. Hayes DC, Secrist H, Bangur CS et al. Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients. Anticancer Res 2006;26:1567-75.
21. Kururu Y, Yamashita J, Ogawa M. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with respectable non-small-cell lung cancer. Surgery 1999;12:820-6.
22. Peck K, Sher YP, Shih JY et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Res 1998;58:2761-5.
23. Rolle A, Günzel R, Pachmann U et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC is a predictor for relapse: a preliminary report. World J Surg Oncol 2005;3:1-9.
24. Sheu CC, Yu YP, Tsai JR. Development of membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer. Int J Cancer 2006;119:1419-26.
25. Sher Y-P, Shih J-Y, Yang P-C et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 2005;11:173-9.
26. Sozzi G, Conte D, Leon M et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3891-3.
27. Sawabata N, Okumura M, Utsumi T et al. Circulating tumor cells in peripheral blood causes by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg 2007;55:189-92.
28. Yamashita J, Matsuo A, Kurusu Y et al. Pre-operative evidence of circulating tumor cells by means of reverse transcriptase-PCR for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg 2002;124:299-305.
29. Hofman V, Bonnetaud C, Ilie MI et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2010. doi: [Epub ahead of print].
30. Coello MC, Luketich JD, Litle VR, Godfrey TE. Prognostic significance of micrometastasis in non-small-cell lung carcinoma. Clin Lung Cancer 2004;5:214-25.
31. Naruke T, Tsuchiya R, Kondo H et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-64.
32. Pfannschmidt J, Muley T, Bülzebruck H et al. Prognostic-assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer 2007;55:371-7.
33. Mountain CF. The international system for staging lung cancer. Sem Surg Oncol 2000;18:106-15.
34. Travis WD, Brambilla E, Müller-Hermelink K, Harris CC. Pathology and Genetics; Tumours of the Lung, Pleura, Thymus and Heart. Lyon: WHO IARC; 2004.
35. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley; 1981.
36. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
37. Atkinson B. Atlas of Diagnostic Cytopathology, 2nd edn. Philadelphia, PA: W. B. Saunders Company; 2004.
38. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009;6:339-51.
39. Mancuso P, Burlini A, Pruneri G et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001;97:3658-61.
40. Strijbos MH, Gratama JW, Kraan J et al. Circulating endothelial cells in oncology: pitfalls and promises. Br J Cancer 2008;98:1731-5.
41. Katz RL, He W, Khanna A et al. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 2010;16:3976-87.